Taiwan Food and Drug Administration of the Ministry of Health and Welfare (TFDA) held an international pharmaceutical conference titled "Building Better Pharmaceutical Care with Technology" at the Taipei International Convention Center on October 25, 2023 (Wednesday). The conference featured a lineup of prominent domestic and international experts and scholars as speakers, including Mr. Paul Sinclair, President of the International Pharmaceutical Federation (FIP), Dr. Yusuke Nakamura, President  of the National Institute of Biomedical Innovation, Health and Nutrition (NIBOHN) in Japan, Dr. Hiroyuki ARAI, Executive Director of the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan, Dean Shin Jai-Goo from the College of Pharmacy at Inje University in South Korea, Director-General Wu Hsiu-Mei of the FDA, and Professor Lee You-Chien from the Institute of Medical Informatics at Taipei Medical University. This conference aimed to provide both domestic and international participants with insights into the innovative trends of technology in pharmaceutical development and pharmaceutical services on a global scale.

In recent years, with the rapid advancement of smart technologies such as artificial intelligence, cloud computing, and mobile devices, the medical field has seen remarkable progress. These technologies have found innovative applications in various aspects, including drug development, precision medicine, healthcare, and pharmaceutical services. They have not only enhanced the safety and efficacy of medications and medical equipment but have also accelerated the delivery of healthcare services, enabling patients to receive the treatment and care they need more efficiently. This international pharmaceutical conference aimed to share the policy initiatives and clinical experiences of different countries in using technology in the field of medicine. It provided a platform for professionals from around the world to exchange knowledge and ideas, with the hope of bringing new perspectives and developments to the pharmaceutical industry and pharmaceutical services.